G-NiiB® is the registered trademark of GenieBiome Limited. GenieBiome, a biotechnology spinout from The Chinese University of Hong Kong was founded by world-renowned clinician-scientists and supported by a multidisciplinary team of experts in microbiology, metagenomics, bioinformatics, disease biomarkers, food technology, clinical trials, IP development and commercialization. For over a decade, our team has pioneered the use of microbiome with evidence-based science to tackle a myriad of diseases, including COVID-19, colorectal cancer, obesity, eczema, and autism. Our precision portfolio of G-NiiB includes diagnostic and risk prediction tests, next-generation microbiome precision formula, and precision medicine tailored for the Asian population. ------------ G-NiiB® 是精進微生物科技有限公司 GenieBiome Ltd 及其子公司的註冊商標。 G-NiiB 是一家由香港中文大學衍生出來的生物科技公司,由世界知名的臨床醫生科學家創立,並由微生物學,宏基因組學,生物信息學,疾病生物標誌物,食品技術,臨床試驗,知識產權開發和商業策略的多學科專家團隊提供支持。十多年來,我們團隊率先從科學論證微生物群的應用,以應對多種疾病,包括COVID-19,結直腸癌,肥胖,濕疹和自閉症。我們的精準微生態診斷及風險測試、精準微生態平衡配方、新一代天然活菌及治療,專為亞洲人而設。